Nomograms for estimating survival in patients with papillary thyroid cancer after surgery

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Mao Y, Xing M. Recent incidences and differential trends of thyroid cancer in the USA. Endocr Relat Cancer. 2016;23(4):313–322. doi:10.1530/ERC-15-044526917552
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi:10.1089/thy.2015.002026462967
   PubMed Web of Science ®Google Scholar
• Liu FH, Kuo SF, Hsueh C, Chao TC, Lin JD. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. J Surg Oncol. 2015;112(2):149–154. doi:10.1002/jso.2396726175314
   PubMed Web of Science ®Google Scholar
• Grant CS. Recurrence of papillary thyroid cancer after optimized surgery. Gland Surg. 2015;4(1):52–62. doi:10.3978/j.issn.2227-684X.2014.12.0625713780
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.2138828094848
   PubMed Web of Science ®Google Scholar
• Ho AS, Wang L, Palmer FL, et al. Postoperative nomogram for predicting cancer-specific mortality in medullary thyroid cancer. Ann Surg Oncol. 2015;22(8):2700–2706. doi:10.1245/s10434-014-4208-225366585
   PubMed Web of Science ®Google Scholar
• Tang J, Kong D, Cui Q, et al. Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes. World J Surg Oncol. 2018;16(1):45. doi:10.1186/s12957-018-1340-729506526
   PubMedGoogle Scholar
• Feng J, Shen F, Cai W, Gan X, Deng X, Xu B. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis. Endocrine. 2018. doi:10.1007/s12020-018-1644-y
   PubMed Web of Science ®Google Scholar
• Shi LY, Liu J, Yu LJ, Lei YM, Leng SX, Zhang HY. Clinic-pathologic features and prognostic analysis of thyroid cancer in the older adult: a SEER based study. J Cancer. 2018;9(15):2744–2750. doi:10.7150/jca.2462530087716
   PubMed Web of Science ®Google Scholar
• Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. Journal Clinical Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
   PubMed Web of Science ®Google Scholar
• Attiyeh MA, Fernandez-Del Castillo C, Al Efishat M, et al. Development and validation of a multi-institutional preoperative nomogram for predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: a report from the pancreatic surgery consortium. Ann Surg. 2018;267(1):157–163. doi:10.1097/SLA.000000000000201528079542
   PubMed Web of Science ®Google Scholar
• Chen S, Lai Y, He Z, et al. Establishment and validation of a predictive nomogram model for non-small cell lung cancer patients with chronic hepatitis B viral infection. J Transl Med. 2018;16(1):116. doi:10.1186/s12967-018-1496-529728103
   PubMedGoogle Scholar
• Sonpavde G, Pond GR, Rosenberg JE, et al. Nomogram to assess the survival benefit of new salvage agents for metastatic urothelial carcinoma in the era of immunotherapy. Clin Genitourin Cancer. 2018. doi:10.1016/j.clgc.2018.03.016
   Google Scholar
• Roberto M, Botticelli A, Strigari L, et al. Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival. Med Oncol. 2018;35(7):111. doi:10.1007/s12032-018-1166-829923032
   PubMed Web of Science ®Google Scholar
• Kawachi MH, Bahnson RR, Barry M, et al. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw. 2010;8(2):240–262. 20141680
   PubMed Web of Science ®Google Scholar
• Leyh-Bannurah SR, Budaus L, Pompe R, et al. North American population-based validation of the National Comprehensive Cancer Network practice guideline recommendation of pelvic lymphadenectomy in contemporary prostate cancer. Prostate. 2017;77(5):542–548. doi:10.1002/pros.2329228093788
   PubMed Web of Science ®Google Scholar
• Cronin KA, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute. Cancer. 2014;120(Suppl 23):3755–3757. doi:10.1002/cncr.2904925412387
   PubMedGoogle Scholar
• Wolbers M, Koller MT, Witteman JC, Steyerberg EW. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology. 2009;20(4):555–561. doi:10.1097/EDE.0b013e3181a3905619367167
   PubMed Web of Science ®Google Scholar
• Sherman SI, Brierley JD, Sperling M, et al. Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer. 1998;83(5):1012–1021. 9731906
   PubMed Web of Science ®Google Scholar
• Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104(6):947–953. 3194846
   PubMed Web of Science ®Google Scholar
• Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery. 1994;116(6):1036–1040; discussion 1040-1031. 7985084
   PubMed Web of Science ®Google Scholar
• Fang C, Wang W, Feng X, et al. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. Br J Cancer. 2017;117(10):1544–1550. doi:10.1038/bjc.2017.31528949958
   PubMed Web of Science ®Google Scholar
• Wan G, Gao F, Chen J, et al. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma. BMC Cancer. 2017;17:1. doi:10.1186/s12885-017-3062-628049525
   PubMed Web of Science ®Google Scholar
• Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. Journal Clinical Oncol. 2010;28(23):3762–3769. doi:10.1200/JCO.2009.26.8847
   PubMed Web of Science ®Google Scholar
• Weiser MR, Landmann RG, Kattan MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. Journal Clinical Oncol. 2008;26(3):380–385. doi:10.1200/JCO.2007.14.1291
   PubMed Web of Science ®Google Scholar
• Shah S, Boucai L. Effect of age on response to therapy and mortality in patients with thyroid cancer at high risk of recurrence. J Clin Endocrinol Metab. 2018;103(2):689–697. doi:10.1210/jc.2017-0225529220531
   PubMed Web of Science ®Google Scholar
• Shen W, Sakamoto N, Yang L. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis. Ann Surg Oncol. 2015;22(1):264–271. doi:10.1245/s10434-014-3951-825074664
   PubMed Web of Science ®Google Scholar
• Skillington SA, Kallogjeri D, Lewis JS Jr. , Piccirillo JF. Prognostic importance of comorbidity and the association between comorbidity and p16 in oropharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2016;142(6):568–575. doi:10.1001/jamaoto.2016.034727077485
   PubMed Web of Science ®Google Scholar
• Wray CJ, Phatak UR, Robinson EK, et al. The effect of age on race-related breast cancer survival disparities. Ann Surg Oncol. 2013;20(8):2541–2547. doi:10.1245/s10434-013-2913-x23435633
   PubMed Web of Science ®Google Scholar
• Tang J, Kong D, Cui Q, et al. The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER. Onco Targets Ther. 2018;11:3551–3560. doi:10.2147/OTT.S16075229950860
   PubMed Web of Science ®Google Scholar
• Kwong N, Medici M, Angell TE, et al. The influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk. J Clin Endocrinol Metab. 2015;100(12):4434–4440. doi:10.1210/jc.2015-310026465395
   PubMed Web of Science ®Google Scholar
• Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol. 2010;6(11):1771–1779. doi:10.2217/fon.10.12721142662
   PubMed Web of Science ®Google Scholar
• Zhang D, Tang J, Kong D, et al. Impact of gender and age on the prognosis of differentiated thyroid carcinoma: a retrospective analysis based on SEER. Horm Cancer. 2018;9(5):361–370. doi:10.1007/s12672-018-0340-y30014218
   PubMed Web of Science ®Google Scholar